XML 41 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Discontinued Operations - (Details) - USD ($)
shares in Thousands, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 27, 2015
Feb. 10, 2015
Apr. 30, 2015
Mar. 31, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
After Tax Gain         $ (1) $ 16 $ 1,736
Gain on sale of Mylan shares             207
Proceeds from the sale of Mylan shares             2,290
Proceeds from the disposition of business           $ 25 $ 230
Developed markets branded generics pharmaceuticals business              
Value of shares received for sale of generics pharmaceuticals business to Mylan Inc $ 5,770            
After Tax Gain $ 1,600            
Developed markets branded generics pharmaceuticals business | Minimum              
Period for providing manufacturing supply of products 3 years            
Developed markets branded generics pharmaceuticals business | Maximum              
Period of transition services 2 years            
Period for providing manufacturing supply of products 10 years            
Period of notice require to terminate manufacturing supply of products 2 years            
Animal Health Business              
After Tax Gain   $ 130   $ 16      
Proceeds from the disposition of business   $ 230   $ 25      
Mylan              
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc     110,000        
Number of shares in investment sold     40,250        
Gain on sale of Mylan shares         207    
Proceeds from the sale of Mylan shares         2,290    
Mylan | Developed markets branded generics pharmaceuticals business              
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc 110,000            
Percentage of shares received for sale of generics pharmaceuticals business to Mylan Inc 22.00%            
Gain on sale of Mylan shares         207    
Proceeds from the sale of Mylan shares         $ 2,290    
Mylan NV              
Ownership interest (as a percent)     14.00%   14.00%   14.00%
Mylan NV | Developed markets branded generics pharmaceuticals business              
Number of shares received for sale of generics pharmaceuticals business to Mylan Inc         110,000    
Number of shares in investment sold         40,300